Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alisa Jennifer Prager, M.D.

Concepts (136)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glaucoma7202211851.220 Why?
Visual Fields3202110620.890 Why?
Visual Field Tests320214110.770 Why?
Neurocutaneous Syndromes12021530.710 Why?
Arteriovenous Fistula120213190.580 Why?
Eye Diseases220226530.560 Why?
Tomography, Optical Coherence3202229170.540 Why?
Macula Lutea120171770.520 Why?
Fluorescein Angiography1202110590.500 Why?
Retinal Vessels120218520.490 Why?
Glaucoma, Open-Angle120217380.460 Why?
Vision Disorders1202110880.440 Why?
Retinal Ganglion Cells120178110.370 Why?
Visual Acuity2201726720.360 Why?
Disease Management1202125080.350 Why?
Medicare2201867700.320 Why?
Brain Diseases1201515450.250 Why?
Self Report1201637250.230 Why?
Health Care Costs1201632420.210 Why?
Patient Acceptance of Health Care1201632050.200 Why?
Magnetic Resonance Imaging32021364290.200 Why?
Hospitalization22018107210.190 Why?
Medicare Part D220163550.180 Why?
Brain Neoplasms4201590310.180 Why?
beta-Alanine12021820.180 Why?
Ocular Hypertension120222090.180 Why?
Quality of Life42022133670.170 Why?
Blastomycosis12019140.170 Why?
Glioma1201534550.170 Why?
Benzoates120212120.170 Why?
Fundus Oculi120215560.160 Why?
Neoplasm Recurrence, Local2201592800.160 Why?
Dacryocystitis12019680.160 Why?
Scotoma120171300.130 Why?
Health Plan Implementation220163370.130 Why?
Vision, Binocular120172260.130 Why?
Disease Progression32022135100.110 Why?
Hepatocyte Growth Factor120132710.100 Why?
Dacarbazine120155590.100 Why?
Osteopontin120133010.100 Why?
Insulin-Like Growth Factor Binding Protein 3120134160.100 Why?
Health Services Research1201818120.090 Why?
Prostatic Neoplasms12013111220.090 Why?
Drug Costs2201611830.090 Why?
Confidence Intervals1201629270.090 Why?
Cost Savings120159130.090 Why?
Cross-Sectional Studies42018261270.080 Why?
Brain Stem Neoplasms120111900.080 Why?
Area Under Curve1201316380.080 Why?
Antihypertensive Agents2201620240.080 Why?
Metabolic Networks and Pathways120137890.080 Why?
Prescription Drugs120166310.080 Why?
Radiotherapy1201514990.070 Why?
Glioblastoma2201334820.070 Why?
Ophthalmic Solutions220223130.070 Why?
Aged1020181693100.070 Why?
Humans2020227615720.070 Why?
Interferon-alpha120119210.070 Why?
Kidney Transplantation1202242350.070 Why?
Enzyme-Linked Immunosorbent Assay1201338100.070 Why?
Artificial Intelligence1202125780.070 Why?
Molecular Imaging120138150.070 Why?
Female1520213926860.070 Why?
Polyethylene Glycols1201111890.060 Why?
ROC Curve1201335790.060 Why?
Radiation Injuries1201311890.060 Why?
Diagnosis, Differential12021129750.060 Why?
Male1420183608420.060 Why?
Insurance Coverage1201619400.060 Why?
Comorbidity12018105080.060 Why?
Prostate-Specific Antigen1201324690.060 Why?
Diabetes Mellitus1202258410.060 Why?
Odds Ratio1201696460.060 Why?
Neurosurgical Procedures1201520720.060 Why?
Medication Adherence1201521760.060 Why?
Radiosurgery1201313420.060 Why?
Aged, 80 and over32018589860.050 Why?
Databases, Factual1201879670.050 Why?
Longitudinal Studies22016146070.050 Why?
Middle Aged620212209200.050 Why?
Hypertension1202285400.050 Why?
United States42018723350.050 Why?
Socioeconomic Factors1201678270.050 Why?
Sensitivity and Specificity22013146660.050 Why?
Retrospective Studies32022806460.050 Why?
Logistic Models12016132550.050 Why?
Diffusion Magnetic Resonance Imaging1201227910.050 Why?
Antineoplastic Agents22015136420.040 Why?
Neoplasm Staging12013111210.040 Why?
Electromagnetic Fields120002960.040 Why?
Incidence12016213550.040 Why?
Sickness Impact Profile120172990.030 Why?
Prognosis22013296290.030 Why?
Intraocular Pressure1202212940.030 Why?
Prospective Studies22017544260.030 Why?
Antibodies, Monoclonal1201291770.030 Why?
Follow-Up Studies12017391070.030 Why?
Risk Assessment12016239960.030 Why?
Cysts120196810.030 Why?
Financing, Personal120163090.030 Why?
Visual Cortex1200011080.020 Why?
Drug Utilization1201511880.020 Why?
Tissue Distribution1201322640.020 Why?
Graft Rejection1202244460.020 Why?
Necrosis1201316110.020 Why?
Gene Amplification1201310890.020 Why?
Income1201618770.020 Why?
Brain12013271200.020 Why?
Preoperative Care1201322420.010 Why?
Up-Regulation1201341240.010 Why?
Lacrimal Apparatus119662230.010 Why?
Drug Administration Schedule1201148530.010 Why?
Health Expenditures1201623660.010 Why?
Recombinant Proteins1201165340.010 Why?
Disease-Free Survival1201168150.010 Why?
Phosphenes12000410.010 Why?
Combined Modality Therapy1201185280.010 Why?
Sensory Thresholds120003770.010 Why?
Dose-Response Relationship, Radiation120008820.010 Why?
Adolescent32013883240.010 Why?
Reproducibility of Results12013200990.010 Why?
Electric Stimulation1200017360.010 Why?
Electromyography1200013940.010 Why?
Reference Values1200049200.010 Why?
Motor Cortex1200010070.010 Why?
Adult420132212030.010 Why?
Infant22011361920.010 Why?
Child, Preschool22011422300.010 Why?
Transcranial Magnetic Stimulation1200014730.010 Why?
Lung Neoplasms12013133820.000 Why?
Aging1196687110.000 Why?
Young Adult12013592550.000 Why?
Breast Neoplasms12013210170.000 Why?
Child22011801560.000 Why?
Conjunctivitis119661550.000 Why?
Atrophy1196616330.000 Why?
Prager's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (136)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.